Scpharmaceuticals Stock Technical Analysis

SCPH Stock  USD 4.53  0.14  3.19%   
As of the 16th of July 2025, Scpharmaceuticals has the Semi Deviation of 2.96, risk adjusted performance of 0.221, and Coefficient Of Variation of 472.2. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scpharmaceuticals, as well as the relationship between them.

Scpharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Scpharmaceuticals, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ScpharmaceuticalsScpharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Scpharmaceuticals Analyst Consensus

Target PriceAdvice# of Analysts
15.17Strong Buy6Odds
Scpharmaceuticals current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Scpharmaceuticals analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Scpharmaceuticals stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Scpharmaceuticals, talking to its executives and customers, or listening to Scpharmaceuticals conference calls.
Scpharmaceuticals Analyst Advice Details
Scpharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Scpharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Scpharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Scpharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Scpharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Scpharmaceuticals Trend Analysis

Use this graph to draw trend lines for Scpharmaceuticals. You can use it to identify possible trend reversals for Scpharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Scpharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Scpharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Scpharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.04  , which means Scpharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 51.45, which is the sum of squared deviations for the predicted Scpharmaceuticals price change compared to its average price change.

About Scpharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Scpharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Scpharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Scpharmaceuticals price pattern first instead of the macroeconomic environment surrounding Scpharmaceuticals. By analyzing Scpharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Scpharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Scpharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2025 (projected)
Payables Turnover0.952.933.07
Days Of Inventory On Hand846.65446.67424.33

Scpharmaceuticals July 16, 2025 Technical Indicators

Most technical analysis of Scpharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Scpharmaceuticals from various momentum indicators to cycle indicators. When you analyze Scpharmaceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Scpharmaceuticals July 16, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Scpharmaceuticals stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Scpharmaceuticals Stock analysis

When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data